Ocular Therapeutix Inc. buy Chardan Capital
Start price
09.12.25
/
50%
€13.61
Target price
09.12.26
€18.03
Performance (%)
-28.92%
Price
09.01.26
€9.67
Summary
This prediction is currently active. The prediction for Ocular Therapeutix Inc. disappoints with a performance of -28.92%. This prediction currently runs until 09.12.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | -4.170% | -4.170% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by Chardan_Capital for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Stopped prediction by Chardan_Capital for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.36
05.11.25
05.11.25
€18.27
05.11.26
05.11.26
3.35%
09.01.26
09.01.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.43
02.10.25
02.10.25
€17.89
02.10.26
02.10.26
2.63%
09.01.26
09.01.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€10.62
15.09.25
15.09.25
€17.90
15.09.26
15.09.26
-8.86%
09.01.26
09.01.26